It didn’t take long for the rumour of Gildan’s $5B bid for Hanes to materialize… and better than expected too - with a lower $4.4B price tag representing an 8.9x EBITDA multiple (6.3x post-synergies) that the market rewarded with a 15% bump in shares.

Gildan elected to finance nearly 90% of the equity value with stock - keeping pro-forma leverage at a modest 2.6x, which management expects to get back below 2x shortly with the help of a buyback pause and divestiture of HBI’s Australian unit.

Purchase price: check, financing package: check, strategic rationale: interesting. Cost savings are pegged at ~$200M via higher capacity utilization, overlap in the product mix & manufacturing footprint, and debt refinancing…

… supporting its 3-year guidance for ~20%/yr EPS growth. The combined company is more balanced, both in the products it makes and the path those products take to market.

But most interesting for the long-term investor is how management frames why this transaction works:

… and contrary to what Hanes has been doing, investing in their brand, Gildan has been investing in low-cost vertically integrated manufacturing… that’s where all of our capital has gone in.

Glenn Chamandy (CEO) - GIL M&A call

Gildan’s manufacturing expertise is the durable advantage - it’s the heartbeat of retail. If it can digest this deal well, don’t be surprised to see it acquire more extremities in the future…

You might be interested in…

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.